ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma.

Pingyan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.